Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Pensionfund Sabic

Pensionfund Sabic grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 42.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,200 shares of the company's stock after acquiring an additional 4,200 shares during the quarter. Pensionfund Sabic's holdings in Cardinal Health were worth $1,679,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CAH. Eastern Bank purchased a new stake in Cardinal Health during the 3rd quarter worth approximately $25,000. Frazier Financial Advisors LLC grew its holdings in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after buying an additional 104 shares during the last quarter. Ashton Thomas Private Wealth LLC acquired a new position in shares of Cardinal Health in the 2nd quarter valued at $29,000. Hara Capital LLC purchased a new position in Cardinal Health in the 3rd quarter worth $31,000. Finally, AM Squared Ltd acquired a new stake in Cardinal Health during the 3rd quarter worth about $33,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH traded up $0.18 on Monday, hitting $119.48. 2,777,674 shares of the company's stock were exchanged, compared to its average volume of 1,991,158. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $126.23. The firm's 50-day moving average is $118.80 and its 200 day moving average is $110.45. The company has a market capitalization of $28.92 billion, a PE ratio of 23.25, a P/E/G ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm's revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 earnings per share. On average, analysts anticipate that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health's dividend payout ratio is presently 39.30%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on CAH shares. Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $132.00 to $145.00 in a report on Monday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. Barclays upped their price target on Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a report on Monday, November 4th. Wells Fargo & Company raised shares of Cardinal Health from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $101.00 to $127.00 in a report on Friday, December 13th. Finally, Morgan Stanley lifted their price target on Cardinal Health from $127.00 to $136.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $128.85.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.